Liver Fibrosis Screening System

An integrated diagnostic system that combines radiological and functional screening for pulmonary assessment. The system processes multiple data modalities to enable early detection and accurate patient classification for lung disease management.

Non-invasive diagnostic system designed for early detection of vascular complications in diabetic patients. Enables identification of arterial, venous, and lymphatic system abnormalities to prevent progression to diabetic foot syndrome.

Specialized imaging and diagnostic protocol for early detection of lung cancer, designed to improve survival rates in high-risk patient populations.

Specialized imaging technology for early detection and diagnosis of lung cancer. Integrates AI-assisted analysis to improve diagnostic accuracy and clinical outcomes.

A diagnostic-grade screening system supporting large-scale early screening for populations exceeding one million. It provides an integrated screening and diagnostic workflow applicable to regional and community-level atrial fibrillation and stroke screening and early diagnosis. The system increases detection rate 8-10 times while reducing costs by 80%.

A comprehensive diagnostic system for detecting peripheral artery disease characterized by arterial stenosis and plaque accumulation. The device combines Doppler and photoplethysmography technologies for multi-modality vascular assessment.

An intelligent screening system designed for early detection and risk assessment of coronary heart disease. The system integrates multiple physiological measurements to identify patients at risk of coronary events.

An AI-powered diagnostic system utilizing deep learning algorithms to rapidly identify and localize breast tumors and assess malignancy potential. The system enables efficient screening and characterization of breast lesions from imaging data.

Non-invasive diagnostic tool for early detection of peripheral neuropathy in diabetic patients. Enables identification of nerve function abnormalities before clinical symptoms manifest.

Fibroscan is a non-invasive and quantitative examination device for the liver, represented by Mediplast through Echosens. The device enables simultaneous examination for fibrosis and steatosis. It is available as an ultra-mobile model for quick and flexible screening outside the clinic.

Low-dose CT systems optimized for lung cancer screening in high-risk populations. These systems enable early detection with minimized radiation burden.

Integrated diagnostic system for comprehensive evaluation of lower extremity arterial disease including pressure measurements and flow analysis. Supports rapid patient risk stratification.